Patients increasingly seek regenerative solutions that deliver meaningful, visible change with minimal downtime. This session explores how the FDA-cleared Pro Pen microneedling system, paired with Exo Booster’s bacteria-based exosomes from Dermalogica Pro, creates a differentiated, high-performance treatment offering in a competitive market. Attendees will gain a clear understanding of the science behind this protocol, how it supports consistent outcomes across providers and how it can scale into a successful microneedling program that aligns with today’s patient expectations. Let your practice harness the next wave of regenerative innovation.